Yüklüyor......
Protein arginine methyltransferase 5 (PRMT5) activates WNT/β‐catenin signalling in breast cancer cells via epigenetic silencing of DKK1 and DKK3
Protein arginine methyltransferase 5 (PRMT5) activity is dysregulated in many aggressive cancers and its enhanced levels are associated with increased tumour growth and survival. However, the role of PRMT5 in breast cancer remains underexplored. In this study, we show that PRMT5 is overexpressed in...
Kaydedildi:
| Yayımlandı: | J Cell Mol Med |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7875925/ https://ncbi.nlm.nih.gov/pubmed/33462997 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.16260 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|